The store will not work correctly when cookies are disabled.
(RR/SS)-2-[1-(3,4-dichlorophenyl)pentyl]piperidine
ID: ALA374634
PubChem CID: 16102765
Max Phase: Preclinical
Molecular Formula: C16H23Cl2N
Molecular Weight: 300.27
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCC(c1ccc(Cl)c(Cl)c1)C1CCCCN1
Standard InChI: InChI=1S/C16H23Cl2N/c1-2-3-6-13(16-7-4-5-10-19-16)12-8-9-14(17)15(18)11-12/h8-9,11,13,16,19H,2-7,10H2,1H3
Standard InChI Key: CCEQAXVCJWOVQY-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
-3.2960 -0.8126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5776 -0.4017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8619 -0.8156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1439 -0.4053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1423 0.4238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8645 0.8410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5797 0.4241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0085 -0.3987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0048 0.4273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7133 0.8412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.4305 0.4346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.4347 -0.3904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2987 -1.6367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4316 -0.8196 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-4.0138 -2.0463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7261 -1.6320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4282 0.8352 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-4.7233 -0.8079 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.4411 -2.0416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4 5 2 0
2 3 2 0
5 6 1 0
8 18 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 18 1 0
1 2 1 0
1 13 1 0
6 7 2 0
4 14 1 0
7 2 1 0
13 15 1 0
3 4 1 0
15 16 1 0
1 8 1 0
5 17 1 0
8 9 1 0
16 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 300.27 | Molecular Weight (Monoisotopic): 299.1208 | AlogP: 5.41 | #Rotatable Bonds: 5 |
Polar Surface Area: 12.03 | Molecular Species: BASE | HBA: 1 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 1 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 10.22 | CX LogP: 5.64 | CX LogD: 2.96 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.77 | Np Likeness Score: -0.05 |
References
1. Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A.. (2007) Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter., 50 (2): [PMID:17228864] [10.1021/jm0608614] |
2. Froimowitz M, Gu Y, Dakin LA, Nagafuji PM, Kelley CJ, Parrish D, Deschamps JR, Janowsky A.. (2007) Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter., 50 (2): [PMID:17228864] [10.1021/jm0608614] |